AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31109368
Drug: TMQLB group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMQLB group 2 (0.6 ml/kg body weight 0.5% ropivacaine)
Trial: 31109368
Drug: TPVB control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPVB control group (0.4 ml/kg body weight 0.5% ropivacaine at vertebra T10)
Trial: 23954912
Drug: Oral α‐methyl‐para‐tyrosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral α‐methyl‐para‐tyrosine (catecholamine depletion)
Trial: 21471564
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (vinorelbine-cisplatin)
Trial: 9708399
Drug: SQV-SGC 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQV-SGC 1200 mg three times a day for 16 weeks
Trial: 9708399
Drug: SQV-HGC 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQV-HGC 600 mg three times a day for 16 weeks
Trial: 27568322
Drug: Trastuzumab in
RxNorm normalized name: trastuzumab Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab in combination with cisplatin and fluoropyrimidines
Trial: 25048952
Drug: Avatrombopag (100mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avatrombopag (100mg loading dose followed by 20, 40, or 80 mg/day on days 2‐7)
Trial: 25048952
Drug: Avatrombopag (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avatrombopag (80 mg loading dose followed by 10 mg/day for days 2‐7, or 20mg/day for days 2‐4)
Trial: 20018286
Drug: Rosuvastatin 20mg/daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 20mg/daily
Trial: 20018286
Drug: Simvastatin 20mg/daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20mg/daily
Trial: 19543080
Drug: Nifedipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (30 mg/day) at bedtime
Trial: 12714817
Drug: 5-FU (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (60 mg/kg body weight) for 48 hours
Trial: 12714817
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (FA) (500 mg/m2) for 2 hours and 5-FU (2600 mg/m2) for 24 hours
Trial: 29534310
Drug: Non-CC genotype
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-CC genotype patients
Trial: 22652101
Drug: Silver clear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver clear nylon dressing (SCND) applied from Day 1 of radiation therapy until 2 weeks after treatment completion
Trial: 22652101
Drug: Standard skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard skin care (sulfadiazine cream applied at the time of skin dermatitis)
Trial: 20590587
Drug: Oxycodone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 0.2 mg x kg(‐1) + Quinidine (CYP2D6 inhibitor)
Trial: 20590587
Drug: Oxycodone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 0.2 mg x kg(‐1) + Quinidine + Ketoconazole
Trial: 10411811
Drug: Oral methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral methotrexate (50 mg/m²)
Trial: 6940435
Drug: High cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High cholesterol diet (1400 mg cholesterol/day)
Trial: 6940435
Drug: Normal cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal cholesterol diet (400 mg cholesterol/day)
Trial: 11216321
Drug: Hypnotic procedures
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic procedures at testing
Trial: 27296705
Drug: Atorvastatin/ezetimibe combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin/ezetimibe combination
Trial: 29096836
Drug: Atorvastatin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin alone
Trial: 21464053
Drug: β-blocker use
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blocker use
Trial: 16023653
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogen (CEE)
Trial: 12546339
Drug: TAA nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA nasal spray 110 microg
Trial: 12546339
Drug: TAA nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA nasal spray 220 microg
Trial: 8889902
Drug: Yohimbine hydrochloride,
RxNorm normalized name: Yohimbine Hydrochloride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine hydrochloride, single oral doses up to 21.6 mg
Trial: 8889902
Drug: Yohimbine hydrochloride,
RxNorm normalized name: Yohimbine Hydrochloride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine hydrochloride, single oral doses
Trial: 8889902
Drug: Yohimbine hydrochloride,
RxNorm normalized name: Yohimbine Hydrochloride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine hydrochloride, higher doses
Trial: 8889902
Drug: Yohimbine hydrochloride,
RxNorm normalized name: Yohimbine Hydrochloride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine hydrochloride, administration with high fat meal
Trial: 31797203
Drug: Icotinib combined
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Icotinib combined with local radiotherapy and subcutaneous injection of GM-CSF
Trial: 18201581
Drug: Ropinirole 24-hour
RxNorm normalized name: ropinirole
DrugBank: Ropinirole (DB00268)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ropinirole 24-hour prolonged release 8 mg QD
Trial: 18201581
Drug: Ropinirole 24-hour
RxNorm normalized name: ropinirole
DrugBank: Ropinirole (DB00268)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ropinirole 24-hour prolonged release (2-, 4-, and 8-mg tablets)
Trial: 15197192
Drug: IV vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV vinorelbine 25 mg/m(2) on days 1 and 8 plus IV epirubicin 90 mg/m(2) on day 1
Trial: 8575054
Drug: Pancuronium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (0.1 mg/kg)
Trial: 20053325
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with alefacept
Trial: 17513945
Drug: Diuretic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic therapy (hydrochlorothiazide 25 mg plus amiloride 5 mg)
Trial: 15551394
Drug: Solanum xanthocarpum
RxNorm normalized name: solanum xanthocarpum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solanum xanthocarpum and Solanum trilobatum (300 mg tds for 3 days)
Trial: 11435848
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (noncontact neodymium (Nd):YAG visual laser assisted prostatectomy)
Trial: 8750567
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin
Trial: 29798480
Drug: Unilateral A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral A group (only cochlear implant)
Trial: 20507953
Drug: Intensive renal
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive renal replacement therapy
Trial: 17090995
Drug: Daily fluid
RxNorm normalized name: ENSULIZOLE 4 g in 100 mL / OCTINOXATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / TITANIUM DIOXIDE 5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [EXEL CLARIFYING LINE DAILY FLUID SUN SHIELD WHITE COLOR BROAD SPECTRUM SPF 60 PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily fluid intake measurement (1,035 ml average, SD=359 ml, range 210 ml to 2,050 ml)
Trial: 4025160
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker therapy (verapamil or nifedipine)
Trial: 29722846
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 (2 oral doses of 200,000 IU at 2 and 4 weeks)
Trial: 28692301
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3
Trial: 23935398
Drug: Cilnidipine (10.27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilnidipine (10.27 ± 4.13 mg/day)
Trial: 23935398
Drug: Amlodipine (4.87
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (4.87 ± 2.08 mg/day)
Trial: 17983434
Drug: Oxybutynin transdermal
RxNorm normalized name: oxyBUTYnin Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin transdermal system (OXY‐TDS) 3.9 mg/day
Trial: 15725084
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose melphalan-prednisone (MP)
Trial: 4052143
Drug: Flupirtine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupirtine (3 X 100 mg on the previous day and 100 mg before the test)
Trial: 4052143
Drug: Diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10 mg perorally 2 days before and 5 mg perorally on the preceding day)
Trial: 29265699
Drug: Indocyanine green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indocyanine green administration at 3, 6, 9, 12, 15, 18, and 24 hours before surgery
Trial: 11064964
Drug: Waiting list,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting list, no-treatment or placebo control group
Trial: 8520059
Drug: Human leukocyte
RxNorm normalized name: Human leukocyte antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human leukocyte interferon-alpha cream (2 x 10(6) IU/g)
Trial: 8457025
Drug: Ipratropium 40
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium 40 micrograms four times daily
Trial: 3092392
Drug: Glibenclamide and
RxNorm normalized name: Glibenclamide and metformin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide and metformin
Trial: 20465593
Drug: Wireless motility
RxNorm normalized name: careless weed pollen extract
DrugBank: Amaranthus palmeri pollen (DB10459)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wireless motility capsule (WMC)
Trial: 22572600
Drug: Wireless motility
RxNorm normalized name: careless weed pollen extract
DrugBank: Amaranthus palmeri pollen (DB10459)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wireless motility capsule (WMC) and Radioopaque markers (ROM)
Trial: 16434463
Drug: 20% lipid/heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% lipid/heparin infusion
Trial: 16434463
Drug: saline/heparin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saline/heparin infusion
Trial: 12208800
Drug: Tranilast (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranilast (300 and 450 mg BID for 1 or 3 months)
Trial: 10335729
Drug: Primary care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary care specialty (family medicine, medicine, pediatrics, joint medicine and pediatrics)
Trial: 1958451
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg three times daily with ranitidine 300 mg twice daily
Trial: 1958451
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg three times daily with cimetidine 800 mg daily
Trial: 31789723
Drug: Long-term medical
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term medical therapy (up to 10 years)
Trial: 28650680
Drug: Finasteride, 5
RxNorm normalized name: Finasteride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride, 5 mg per day for 4 weeks
Trial: 31889148
Drug: MF59-adjuvanted trivalent
RxNorm normalized name: Influenza, adjuvanted, trivalent, PF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted trivalent influenza vaccine (ATIV)
Trial: 14748901
Drug: Cholesterol-lowering drug
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering drug treatment
Trial: 11915781
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (200 mg of ascorbic acid twice a day)
Trial: 11915781
Drug: Placebo (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (200 mg of lactose)
Trial: 8307445
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (15 mg orally thrice daily)
Trial: 2661242
Drug: Sustained-release naproxen
RxNorm normalized name: naproxen Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release naproxen (1 g daily)
Trial: 28541500
Drug: Oral hyperimmune
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hyperimmune bovine IgG (bIgG) raised against CFA/I minor pilin subunit (CfaE)
Trial: 25395392
Drug: Oral liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral liposomal iron (30 mg/day)
Trial: 25395392
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron gluconate (1000 mg total, 125 mg infused weekly)
Trial: 23571819
Drug: Bifidobacterium animalis
RxNorm normalized name: Bifidobacterium Animalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacterium animalis subsp. lactis BB-12 (daily dose of 10^10 colony-forming units)
Trial: 23571819
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (xylitol or sorbitol tablets)
Trial: 18995160
Drug: Placement on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placement on a gel pillow (n = 41)
Trial: 16926566
Drug: Distributed practice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distributed practice regimen (weekly)
Trial: 1307461
Drug: Diltiazem (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (180 to 240 mg daily, 3 to 4 tablets a day)
Trial: 7774991
Drug: Nisoldipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (10 mg)
Trial: 26348685
Drug: Relapses, fecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relapses, fecal incontinence, and laxative use
Trial: 24525654
Drug: Sertraline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (200 mg/d)
Trial: 24525654
Drug: Sertraline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline plus Gabapentin (SERT + GBP)
Trial: 15922814
Drug: Sumatriptan 50
RxNorm normalized name: sumatriptan 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 50 mg and 100 mg
Trial: 10626291
Drug: LH-RH agonist
RxNorm normalized name: LH
DrugBank: Luteinizing hormone (DB14741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LH-RH agonist leuprorelin
Trial: 10626291
Drug: Cytotoxic agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic agent treosulfane
Trial: 10626291
Drug: LH-RH agonists
RxNorm normalized name: LH
DrugBank: Luteinizing hormone (DB14741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LH-RH agonists in conventional doses
Trial: 6232015
Drug: 4.0 x
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.0 x 10(6) units of procaine penicillin plus 1 g of probenecid
Trial: 14656841
Drug: Penicillin treatment
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin treatment
Trial: 6232015
Drug: Spectinomycin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectinomycin treatment
Trial: 6232015
Drug: Tetracycline (as
RxNorm normalized name: oxytetracycline (as hydrochloride)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline (as second-line treatment)
Trial: 22048225
Drug: Vaporized cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaporized cannabis inhalation (3 times a day on days 2-4 and in the morning of day 5)
Trial: 22048225
Drug: Sustained-release morphine
RxNorm normalized name: morphine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release morphine or oxycodone (control group)
Trial: 3313202
Drug: Indomethacin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (both doses)
Trial: 21817806
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (IT) aiming for BP < 120/80 mm Hg and LDL-C < 80 mg/dl
Trial: 21817806
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (CT) aiming for BP < 140/90 mm Hg and LDL-C < 100 mg/dl
Trial: 15553105
Drug: Emedastine difumarate
RxNorm normalized name: Emedastine Difumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emedastine difumarate (2 mg b.i.d.)
Trial: 17229605
Drug: Loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (10 mg o.d.)
Trial: 10934673
Drug: rhIL-11 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-11 (25 micrograms/kg s.c. once daily)
Trial: 29503129
Drug: Failure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Failure to complete preoperative chemotherapy
Trial: 18272140
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) treatment for 4 weeks
Trial: 16517559
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone treatment (20 microg/kg per day) for 5 days before gonadotrophin treatment
Trial: 12918077
Drug: Current oral
RxNorm normalized name: black currant oil Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current oral contraceptive use
Trial: 8248274
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil as adjunctive therapy
Trial: 28495197
Drug: Allopurinol 10
RxNorm normalized name: allopurinol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 10 mg/kg PO BID for 180 days
Trial: 26115532
Drug: Relaxation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation therapy
Trial: 19224814
Drug: 8% lidocaine
RxNorm normalized name: LIDOCAINE 18 g in 100 g TOPICAL CREAM [Tattoo Numbing Cream 18% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% lidocaine pump spray (Xylocaine pump spray, XPS)
Trial: 28719982
Drug: Cortisone injection
RxNorm normalized name: hydrocortisone Injection
DrugBank: Cortisone (DB14681)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisone injection
Trial: 29395637
Drug: D +
RxNorm normalized name: Liver Desiccated + B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D + Ca + B (1200 IE vitamin D3, 800 mg Ca-carbonate, 0.5 mg B9, 50 mg B6, 0.5 mg B12)
Trial: 26294207
Drug: Ornipressin (Por‐8,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornipressin (Por‐8, Ferring) solution
Trial: 23082707
Drug: Colpermin (peppermint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colpermin (peppermint oil capsules)
Trial: 20102596
Drug: McKenzie method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: McKenzie method in addition to first-line care (advice, reassurance, and time-contingent acetaminophen)
Trial: 10502624
Drug: Starch based
RxNorm normalized name: THICK & EASY STARCH BASED PWDR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Starch based hot stage extrusion formulation containing 300 mg anhydrous theophylline
Trial: 8604729
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol solution (administered twice daily)
Trial: 8604729
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol gellan (administered once daily)
Trial: 6276746
Drug: Fluoride (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride (one year of treatment)
Trial: 6276746
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of calcium, fluoride, and estrogen
Trial: 31138725
Drug: Docetaxel 50
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 50 mg/m2, Oxaliplatin 85 mg/m2, 5-FU 2400 mg/m2 continuous intravenous infusion over 46 hours, cycles every 2 weeks
Trial: 19922893
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of imatinib 400 mg
Trial: 15606396
Drug: CDP870 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP870 10 mg/kg
Trial: 15606396
Drug: CDP870 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP870 20 mg/kg
Trial: 7898843
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin E2 (PGE2) gel
Trial: 19034329
Drug: Atorvastatin (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10-80 mg/day)
Trial: 17673219
Drug: Atorvastatin-Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin-Placebo group
Trial: 12604544
Drug: 1-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-day treatment with 2 g of valacyclovir twice daily for 1 day